HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D A Scheinberg Selected Research

lintuzumab

9/2003Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias.
11/2000An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.
2/2000Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D A Scheinberg Research Topics

Disease

15Neoplasms (Cancer)
01/2018 - 03/2000
12Leukemia
01/2017 - 03/2000
5Acute Promyelocytic Leukemia
01/2007 - 02/2000
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2014 - 10/2000
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2006 - 03/2000
3Residual Neoplasm
11/2001 - 02/2000
2Wilms Tumor (Wilm's Tumor)
01/2017 - 11/2006
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2007 - 09/2000
2Myeloid Leukemia (Leukemia, Myelocytic)
09/2003 - 02/2000
2Lymphoma (Lymphomas)
01/2002 - 07/2000
2Leukocytosis (Pleocytosis)
09/2001 - 07/2000
2Carcinoma (Carcinomatosis)
03/2001 - 11/2000
1Burkitt Lymphoma (Burkitt's Lymphoma)
03/2014
1Multiple Myeloma
01/2007
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2007
1Pathologic Complete Response
09/2003
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2003
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2002
1Extranodal Extension
03/2001
1Prostatic Neoplasms (Prostate Cancer)
11/2000
1Hematologic Neoplasms (Hematological Malignancy)
07/2000

Drug/Important Bio-Agent (IBA)

8Monoclonal AntibodiesIBA
12/2005 - 02/2000
7Proteins (Proteins, Gene)FDA Link
01/2017 - 03/2000
6AntibodiesIBA
01/2018 - 03/2001
6AntigensIBA
01/2017 - 03/2000
4Radioisotopes (Radionuclides)IBA
12/2005 - 11/2000
3Peptides (Polypeptides)IBA
01/2017 - 03/2000
3lintuzumabIBA
09/2003 - 02/2000
2Messenger RNA (mRNA)IBA
03/2014 - 11/2001
2Immunoconjugates (Immunoconjugate)IBA
12/2005 - 07/2000
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2003 - 09/2000
2Arsenic Trioxide (Trisenox)FDA Link
09/2001 - 07/2000
2Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2000 - 02/2000
2VaccinesIBA
06/2000 - 03/2000
1EpitopesIBA
10/2017
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2017
1HLA-A Antigens (HLA-A)IBA
01/2017
1Chimeric Antigen ReceptorsIBA
01/2017
1Pharmaceutical PreparationsIBA
01/2017
1Oxidoreductases (Dehydrogenase)IBA
01/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017
1Mitochondrial Proteins (Mitochondrial Protein)IBA
03/2014
1peptide deformylaseIBA
03/2014
1actinoninIBA
03/2014
1Transcription Factors (Transcription Factor)IBA
11/2006
1Glycoproteins (Glycoprotein)IBA
09/2003
1Busulfan (Busulfex)FDA Link
09/2003
1CD20 AntigensIBA
01/2002
1IsotopesIBA
11/2001
1Actinium-225IBA
11/2001
1Protein Isoforms (Isoforms)IBA
11/2001
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
09/2001
1Retinoic Acid Receptor alphaIBA
09/2001
1Bismuth-213IBA
11/2000
1Cell Surface ReceptorsIBA
10/2000
1OligonucleotidesIBA
09/2000
1fludarabineIBA
09/2000
1Humanized Monoclonal AntibodiesIBA
07/2000
1Protein Subunit VaccinesIBA
03/2000
1Surface Antigens (Surface Antigen)IBA
02/2000

Therapy/Procedure

12Therapeutics
01/2017 - 04/2000
4Radioimmunotherapy
12/2005 - 11/2000
2Immunotherapy
07/2000 - 06/2000
1Radiotherapy
12/2005
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
09/2003
1Combination Drug Therapy (Combination Chemotherapy)
10/2000
1Remission Induction
02/2000